To summarize, the combination of HCK overexpression and PTPRT loss was associated with some myeloproliferative characteristics such as hyperproliferation and STAT3 upregulation in vitro, and aberrant bone marrow erythroid maturation, polycythemia and splenomegaly in vivo. The gene discussed is HCK; the disease is Splenomegaly.